Why Pfizer's Headwinds May Already Be In The Price

Core Insights - Pfizer (NYSE: PFE) is currently facing multiple challenges including patent expirations, declines in COVID-related products, and increased competition from generic drugs [1] Group 1: Company Challenges - The impact of the COVID product cliff has largely materialized, while other challenges are already recognized by the company [1] Group 2: Analyst Background - The analysis is conducted by a stock analyst with over 20 years of experience in quantitative research, financial modeling, and risk management, focusing on equity valuation and market trends [1]